Ambee Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 2/6
Ambee Pharmaceuticals has a total shareholder equity of BDT24.6M and total debt of BDT445.4M, which brings its debt-to-equity ratio to 1813.9%. Its total assets and total liabilities are BDT556.0M and BDT531.5M respectively. Ambee Pharmaceuticals's EBIT is BDT13.2M making its interest coverage ratio 15.3. It has cash and short-term investments of BDT34.2M.
Key information
1,813.9%
Debt to equity ratio
৳445.37m
Debt
| Interest coverage ratio | 15.3x |
| Cash | ৳34.24m |
| Equity | ৳24.55m |
| Total liabilities | ৳531.46m |
| Total assets | ৳556.02m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AMBEEPHA's short term assets (BDT470.9M) do not cover its short term liabilities (BDT526.0M).
Long Term Liabilities: AMBEEPHA's short term assets (BDT470.9M) exceed its long term liabilities (BDT5.5M).
Debt to Equity History and Analysis
Debt Level: AMBEEPHA's net debt to equity ratio (1674.5%) is considered high.
Reducing Debt: AMBEEPHA's debt to equity ratio has increased from 190.9% to 1813.9% over the past 5 years.
Debt Coverage: AMBEEPHA's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: AMBEEPHA's interest payments on its debt are well covered by EBIT (15.3x coverage).